'Tamoxifen' presentation slideshows

1.79k views • 126 slides

P Pronzato

P Pronzato. Endocrine resistance. Eterogeneity of HR+ tumors. Kaplan-Meier Survival Estimates of Relapse-free Survival and Overall Survival among the 225 Patients with ER+ Disease ,. Fan C et al. N Engl J Med 2006;355:560-569.

792 views • 61 slides

FRANCESCO BOCCARDO

759 views • 59 slides

Rachel Schiff Breast Center Baylor College of Medicine

Estrogen Receptor and EGFR/HER2 Pathways Cross Talk in Breast Cancer Endocrine Resistance. Rachel Schiff Breast Center Baylor College of Medicine. 2/2003. Endocrine Therapies. Lower E level in tumor. Selective ER modulators; antagonist vs. agonist activity.

740 views • 54 slides

De beste aromataseremmer? Natuurlijk exemestaan!

De beste aromataseremmer? Natuurlijk exemestaan!. J.W.R.Nortier 4e jaarlijks mammacarcinoom symposium 29 juni 2005. AROMATASE INHIBITION. androstenedione. estrone. "steroidal inhibitor". testosterone. estradiol. catalytic site. NADPH.

640 views • 53 slides

De beste aromataseremmer? Natuurlijk exemestaan!

De beste aromataseremmer? Natuurlijk exemestaan!. J.W.R.Nortier 4e jaarlijks mammacarcinoom symposium 29 juni 2005. AROMATASE INHIBITION. androstenedione. estrone. "steroidal inhibitor". testosterone. estradiol. catalytic site. NADPH.

647 views • 53 slides

Familial Cancer Risk Assessment: Breast and Ovarian Cancer

Genetics and Primary Care. Familial Cancer Risk Assessment: Breast and Ovarian Cancer. Case 1: Ruth. Ruth, a 35 year old Jewish woman, comes for a family planning visit. You inquire about family health history and find out the following information:

624 views • 44 slides

833 views • 44 slides

Personalizing Medicines

Personalizing Medicines. Tumor Genomics E.g., Trastuzumab (Herceptin). Germline DNA. Tamoxifen: Used to treat estrogen-positive breast cancer. Tamoxifen: Is a Pro-drug. Tamoxifen is a Pro-Drug. Jin Y et al: J Natl Cancer Inst 97:30, 2005. CP1229323-3. CYP2D6 Polymorphisms *4 Allele.

633 views • 43 slides

1.02k views • 40 slides

Endocrine therapy in breast cancer

Endocrine therapy in breast cancer. Dr.Mina Tajvidi Radiation oncologist. Endocrine therapy in breast cancer. Endocrine therapy for hormone receptor positive early stage breast cancer in premenopausal women

998 views • 39 slides

Endometrial carcinoma

2.39k views • 35 slides

Adjuvant Treatment Tamoxifen and Aromatase Inhibitors: EFFICACY

503 views • 31 slides

3rd International BCIRG Conference Anaheim, June 20 to 22, 2002

HOT TOPICS IN BREAST CANCER FROM ASCO 2002 Controversies in Endocrine Therapy of Early Breast Cancer: Adjuvant CT and tamoxifen: Concurrent or sequential? Miguel Martin Medical Oncology Dptment Hospital Universitario San Carlos Madrid (Spain). 3rd International BCIRG Conference

377 views • 29 slides

Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools

Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools. ATLAS and aTTom. Update on current status. adjuvant Tamoxifen Treatment: offer more?. ATLAS and aTTom study design. After several years on adjuvant tamoxifen,

412 views • 28 slides

Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools

Steering Committee meeting, 24 th September 2005 University of Oxford Examination Schools. ATLAS and aTTom. Update on current status. adjuvant Tamoxifen Treatment: offer more?. ATLAS and aTTom study design. After several years on adjuvant tamoxifen,

358 views • 28 slides

Tamoxifen associated changes

580 views • 26 slides

Uncertainty Analyses

289 views • 16 slides

Preparing Your Poster for The Research Forum

Preparing Your Poster for The Research Forum. OUCOM-Tulsa Department of Family Medicine Presented By: Frances Wen, Ph.D. February 23, 2010. WHEN: Thursday, April 8, 2010 WHERE: OU Schusterman Learning Center. OU-Tulsa Research Forum 2009. The Poster. Review instructions!

272 views • 14 slides

Proprietary and Confidential

Ryan Phelan CEO & Founder October 18, 2006. Proprietary and Confidential. About DNA Direct. What We Do Medical and pharmaco- genetic testing and interpretation services firm based in San Francisco, CA. www.DnaDirect.com www.GenesandDrugs.com Who We Are CEO & Founder , Ryan Phelan

173 views • 5 slides